Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
172.14
-0.81 (-0.47%)
At close: Jun 27, 2025, 4:00 PM
172.22
+0.08 (0.05%)
After-hours: Jun 27, 2025, 5:12 PM EDT
Ascendis Pharma Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$218.19
Upside
+26.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $215 → $224 | Buy | Maintains | $215 → $224 | +30.13% | Jun 13, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $201 → $216 | Strong Buy | Maintains | $201 → $216 | +25.48% | Jun 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $196 → $201 | Strong Buy | Maintains | $196 → $201 | +16.77% | Jun 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +16.18% | May 12, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $180 → $250 | Hold → Buy | Upgrades | $180 → $250 | +45.23% | May 5, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $205 → $210 | Buy | Maintains | $205 → $210 | +21.99% | May 2, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $200 → $245 | Buy | Maintains | $200 → $245 | +42.33% | May 2, 2025 |
| Wedbush | Wedbush | Buy Maintains $181 → $212 | Buy | Maintains | $181 → $212 | +23.16% | May 2, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $260 → $280 | Buy | Maintains | $260 → $280 | +62.66% | May 2, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $205 | Buy | Initiates | $205 | +19.09% | Apr 16, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $168 → $200 | Buy | Maintains | $168 → $200 | +16.18% | Mar 18, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $170 → $200 | Buy | Maintains | $170 → $200 | +16.18% | Feb 25, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $220 → $260 | Buy | Maintains | $220 → $260 | +51.04% | Feb 18, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $200 → $225 | Strong Buy | Maintains | $200 → $225 | +30.71% | Feb 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $167 → $168 | Buy | Maintains | $167 → $168 | -2.41% | Feb 13, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $170 | Buy | Reiterates | $170 | -1.24% | Feb 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.